MedTrace Logo

Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study

NCT04645394 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2022-03-28

No results posted yet for this study

Summary

In a quadruple cross-over design, 8 healthy men will receive 3 different formulations of Aronia extract as well as placebo (placebo, aronia, and fermented aronia in 1/6 and 1/1 concentration). The intervention will be given on four separate days at least three days apart. Before consumption, 2 fasting blood samples will be taken. Blood will also be sampled at 60, 120, 240, and 360 minutes post consumption. The blood samples will be analyzed for polyphenolic content with a special focus on anthocyanins.

Conditions

  • Bioavailability

Interventions

DIETARY_SUPPLEMENT

Aronia melanocarpa

Administered once (acute study)

DIETARY_SUPPLEMENT

Fermented Aronia Melanocarpa high dose

Administered once (acute study)

DIETARY_SUPPLEMENT

Fermented Aronia Melanocarpa low dose

Administered once (acute study)

DIETARY_SUPPLEMENT

Placebo

Administered once (acute study)

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-23
Primary Completion
2021-02-01
Completion
2021-02-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645394 on ClinicalTrials.gov